SCI
22August
GefitinibVersusGefitinibPlusPemetrexedandCarboplatinChemotherapyinEGFRMutatedLungCancer
NoronhaV,PatilVM,JoshiA,etal.GefitinibVersusGefitinibPlusPemetrexedandCarboplatinChemotherapyinEGFR-MutatedLungCancer.JournalofClinicalOncology;0:JCO.19..
KumarPrabhash,MBBS,MD,DM,DepartmentofMedicalOncology,TataMemorialCenter,HomiBhabhaNationalInstitute,Parel,Mumbai,Maharashtra,India;Twitter:
TataMemorial;e-mail:kumarprabhashtmhgmail.